Skip to main content Accessibility help
  • Print publication year: 2015
  • Online publication date: March 2015

25 - The evolutionary epidemiology of the hepatitis C virus

from Part III - Combining ecology and phylogenetics

Related content

Powered by UNSILO


Alcantara, L. C., Cassol, S., Libin, P., et al. (2009). A standardized framework for accurate high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Research, 37, W634–642
Alter, H. J., Holland, P. V., Morrow, A. G., et al. (1975). Clinical and serological analysis of transfusion-associated hepatitis. Lancet, 2, 838–841.
Alter, H. J., Purcell, R. H., Holland, P. V. & Popper, H. (1978). Transmissible agent in non-A, non-B hepatitis. Lancet, 1, 459–463.
Alter, H. J., Purcell, R. H., Shih, J. W., et al. (1989). Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine, 321, 1494–1500.
Andernach, I. E., Nolte, C., Pape, J. W. & Muller, C. P. (2009). Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerging Infectious Diseases, 15, 1222–1228.
Arthur, R. R., Hassan, N. F., Abdallah, M. Y., et al. (1997). Hepatitis C antibody prevalence in blood banks in different governorates in Egypt. Transactions of the Royal Society Tropical Medicine Hygiene, 91, 121–124.
Belshaw, R., Sanjuán, R. & Pybus, O. G. (2011). Viral mutation and substitution: units and levels. Current Opinion Virology, 1, 430–435.
Berkes, J. & Cotler, S. J. (2005). Global epidemiology of HCV infection. Current Hepatitis Reports, 4, 125–130.
Bhattacharya, T., Daniels, M., Heckerman, D., et al. (2007). Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science, 315, 1583–1586.
Brimacombe, C. L., Grove, J., Meredith, L. W., et al. (2011) Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. Journal of Virology, 85, 596–605.
Bryant, J. E., Holmes, E. C. & Barrett, A. D. (2007). Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathogens, 3, e75.
Bukh, J. (2012) Animal models for the study of hepatitis C virus infection and related liver disease. Gastroenterology, 142, 1279–1287.
Burbelo, P. D., Dubovi, E. J., Simmonds, P., et al. (2012). Serology-enabled discovery of genetically diverse hepaciviruses in a new host. Journal of Virology, 86, 6171–6178.
Calado, R. A., Rocha, M. R., Parreira, R., et al. (2011). Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. Journal of Medical Virology, 83, 608–615.
Candotti, D., Temple, J., Sarkodie, F. & Allain, J. (2003). Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. Journal of Virology, 77, 7914–7923.
Centers for Disease Control and Prevention. (2014) Hepatitis C information for health professionals., accessed 19 August 2014.
Choo, Q., Kuo, G., Weiner, A., et al. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359–362.
Colina, R., Casane, D., Vasquez, S., et al. (2004). Evidence of intratypic recombination in natural populations of hepatitis C virus. Journal of General Virology, 85, 31–37.
Danta, M., Brown, D., Bhagani, S., et al. (2007). Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS, 21, 983–991.
de Bruijne, J., Schinkel, J., Prins, M., et al. (2009). Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles. Journal of Clinical Microbiology, 47, 3832–3838.
de Oliveira, T., Pybus, O. G., Rambaut, A., et al. (2006). Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature, 444, 836–837.
Deinhardt, F., Holmes, A. W., Capps, R. B. & Popper, H. (1967). Studies on the transmission of human viral hepatitis to marmoset monkeys: I. Transmission of disease, serial passages, and description of liver lesions. Journal Experimental Medicine, 125, 673–688.
Deuffic, S., Buffat, L., Poynard, T. and Valleron, A. J. (1999). Modeling the hepatitis C virus epidemic in France. Hepatology, 29, 1596–1601.
Dorner, M., Horwitz, J. A., Robbins, J. B., et al. (2011). A genetically humanized mouse model for hepatitis C virus infection. Nature, 474, 208–211.
Drexler, J. F., Corman, V. M., Müller, M. A., et al. (2012) Evidence for novel hepaciviruses in rodents. PLoS Pathogen, 9, e1003438.
Drucker, E., Alcabes, P. G. & Marx, P. A. (2001). The injection century: massive unsterile injections and the emergence of human pathogens. Lancet, 358, 1989–1992.
Drummond, A. J., Rambaut, A., Shapiro, B. & Pybus, O. G. (2005). Bayesian coalescent inference of past population dynamics from molecular sequences. Molecular Biology & Evolution, 22, 1185–1192
Ducoulombier, D, Roque-Alfonso, A. M., Di Liberto, G., et al. (2004). Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology, 39, 817–825.
Edlin, B. R. and Carden, M. R. (2006). Injection drug users: the overlooked core of the hepatitis C epidemic. Clinical Infection Diseases, 42, 673–676.
Farci, P., Shimoda, A., Coiana, A., et al. (2000). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science, 288, 339–344.
Farci, P., Quinti, I., Farci, S., et al. (2006). Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proceedings of the National Academy of Sciences USA, 103, 8475–8480.
Farci, P., Wollenberg, K., Diaz, G., et al. (2012). Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis. Proceedings of the National Academy of Sciences USA, 109, 14562–14567.
Frank, C., Mohamed, M. K., Strickland, G. T., et al. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355, 887–891.
Gane, E. J., Stedman, C. A., Hyland, R. H., et al. (2013). Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. New England Journal of Medicine, 368, 34–44.
Ghany, M. G., Nelson, D. R., Strader, D. B., Thomas, D. L. & Seeff, L. B. (2011). An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology, 54, 1433–1444.
Goedert, J. J., Chen, B. E., Preiss, L., Aledort, L. M. & Rosenberg, P. S. (2007). Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940–1990. American Journal of Epidemiology, 165, 1443–1453.
Gray, R. R., Parker, J., Lemey, P., et al. (2011). The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evolutionary Biology, 11, 131.
Gray, R. R., Salemi, M., Klenerman, P. & Pybus, O. G. (2012a). A new evolutionary model for hepatitis C virus chronic infection. PLoS Pathogens, 8, e1002656.
Gray, R. R., Strickland, S. L., Veras, N. M., et al. (2012b). Unexpected maintenance of hepatitis C viral diversity following liver transplantation. Journal of Virology, 86, 8432–8439.
Griffiths, R. C. & Tavare, S. (1994). Sampling theory for neutral alleles in a varying environment. Philosophical Transactions of the Royal Society of London B, 344, 403–410.
Hauri, A. M., Armstrong, G. L. & Hutin, Y. J. (2004). The global burden of disease attributable to contaminated injections given in health care settings. International Journal of STD & AIDS, 15, 7–16.
He, L. F., Alling, D., Popkin, T., et al. (1987). Determining the size of non-A, non-B hepatitis virus by filtration. Journal of Infectious Diseases, 156, 636–640.
Holmes, E. C. (2003). Molecular clocks and the puzzle of RNA virus origins. Journal of Virology, 77, 3893–3897.
Hughes, A. L. & Nei, M. (1988). Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature, 335, 167–170.
Iles, J. C., Harrison, G. L., Lyons, S., et al. (2013). Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect. Infection Genetics and Evolution, 19, 386–394.
Jeannel, D., Fretz, C., Traore, Y., et al. (1998). Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. Journal Medical Virology, 55, 92–97.
Jenkins, G. M., Rambaut, A., Pybus, O. G. & Holmes, E. C. (2002). Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. Journal of Molecular Evolution, 54, 156–165.
Kageyama, S., Agdamag, D. M., Alesna, E. T., et al. (2006). A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. Journal of Medical Virology, 78, 1423–1428.
Kalinina, O., Norder, H., Mukomolov, S. & Magnius, L. O. (2002). A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. Journal of Virology, 76, 4034–4043.
Kamal, S. M. & Nasser, I. A. (2008). Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology, 47, 1371–1383.
Kane, A., Lloyd, J., Zaffran, M., Simonsen, L. & Kane, M. (1999). Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bulletin of the World Health Organization, 77, 801–807.
Kapoor, A., Simmonds, P., Gerold, G., et al. (2011). Characterization of a canine homolog of hepatitis C virus. Proceedings of the National Academy of Sciences USA, 108, 11608–11613.
Kapoor, A, Simmonds, P, Scheel, T. K., et al. (2013) Identification of rodent homologs of hepatitis C virus and pegiviruses. Mbio, 4, e00216–13.
Kenny-Walsh, E. (1999). Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin: Irish Hepatology Research Group. New England Journal of Medicine, 340, 1228–1233.
Kuiken, C. & Simmonds, P. (2009). Nomenclature and numbering of the hepatitis C virus. Methods Molecular Biology, 510, 33.
Kuiken, C., Yusim, K., Boykin, L. & Richardson, R. (2005). The Los Alamos HCV sequence database. Bioinformatics, 21, 379–384.
Lanini, S., Abbate, I., Puro, V., et al. (2010). Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome. BMC Infectious Diseases, 10, 257.
Lee, Y. M., Lin, H. J., Chen, Y. J., et al. (2010). Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. Journal of Medical Virology, 82, 57–68.
Legrand-Abravanel, F., Claudinon, J., Nicot, F., et al. (2007). New natural intergenotypic (2/5) recombinant of hepatitis C virus. Journal of Virology, 81, 4357–4362
Liang, Y., Shilagard, T., Xiao, S. Y., et al. (2009). Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology, 137, 1448–1458.
Lindenbach, B. D., Evans, M. J., Syder, A. J., et al. (2005). Complete replication of hepatitis C virus in cell culture. Science, 309, 623–626.
Linnen, J., Wages, J. Jr., Zhang-Keck, Z. Y., et al. (1996). Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science, 271, 505–508.
Lohmann, V., Körner, F., Koch, J., et al. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science, 285, 110–113.
Lyons, S., Kapoor, A., Sharp, C., et al. (2012). Nonprimate hepaciviruses in domestic horses, United Kingdom. Emerging Infectious Diseases, 18, 1976–1982.
Madhava, V., Burgess, C. & Drucker, E. (2002). Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infectious Diseases, 2, 293–302.
Magiorkinis, G., Magiorkinis, E., Paraskevis, D., et al. (2009). The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Medicine, 6, e1000198.
Makuwa, M., Souquière, S., Telfer, P., et al. (2006). Hepatitis viruses in non-human primates. Journal of Medical Primatology, 35, 384–387.
Manns, M. P, McHutchison, J. G., Gordon, S. C., et al. (2001). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet, 358, 958–965.
Markov, P. V., Pépin, J., Frost, E., et al. (2009). Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa. Journal of General Virology, 90, 2086–2096.
Markov, P. V., van de Laar, T. J., Thomas, X. V., et al. (2012). Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. Journal of Virology, 86, 7677–7687.
Markov, P. V., Timm, J., Barnes, E., et al. (2013). Hepatitis C virus is capable of adapting to HLA I in the population [abstract]. In Proceedings of the 10th International Meeting on Microbial Epidemiological Markers, 2013 October 2–5. Paris: Institut Pasteur, p. 216.
Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L. & Simmonds, P. (1995). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. Journal of General Virology, 76, 2493–2507.
Mizokami, M., Tanaka, Y. & Miyakawa, Y. (2006). Spread times of hepatitis C virus estimated by the molecular clock differ among Japan, the United States and Egypt in reflection of their distinct socioeconomic backgrounds. Intervirology, 49, 28–36.
Morishima, C., Polyak, S. J., Ray, R., et al. (2006). Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. Journal of Infectious Diseases, 193, 931–940.
Murphy, D., Chamberland, J., Dandavino, R., et al. (2007). A new genotype of hepatitis C virus originating from Central Africa. Hepatology, 46(4) Suppl.1: 623A.
Ndjomou, J., Pybus, O. G. & Matz, B. (2003). Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. Journal of General Virology, 84, 2333–2341.
Nerrienet, E., Pouillot, R., Lachenal, G., et al. (2005). Hepatitis C virus infection in Cameroon: a cohort-effect. Journal of Medical Virology, 76, 208–214.
Neumann-Haefelin, C., Frick, D. N., Wang, J. J., et al. (2008). Analysis of the evolutionary forces in an immunodominant CD8 epitope in the hepatitis C virus at a population level. Journal of Virology, 82, 3438–3451.
Njouom, R., Nerrienet, E., Dubois, M., et al. (2007). The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infection Genetics and Evolution, 7, 361–367.
Njouom, R., Frost, E., Deslandes, S., et al. (2009). Predominance of hepatitis C virus genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. Journal of General Virology, 90, 2452–2456.
Njouom, R., Caron, M., Besson, G., et al. (2012). Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, Central Africa. PLoS One, 7, e42002.
Parham, P. & Ohta, T. (1996). Population biology of antigen presentation by MHC class I molecules. Science, 272, 67–74.
Pawlotsky, J. M., Tsakiris, L., Roudotthoraval, F., et al. (1995). Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. Journal of Infectious Diseases, 171, 1607–1610.
Pépin, J. & Labbé, A. C. (2008). Noble goals, unforeseen consequences: control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses. Tropical Medicine and International Health, 13, 744–753
Pépin, J., Lavoie, M., Pybus, O. G., et al. (2010). Risk factors for hepatitis C virus transmission in colonial Cameroon. Clinical Infectious Diseases, 51, 768–776.
Perz, J. F., Farrington, L. A, Pecoraro, C., et al. (2004). Estimated global prevalence of hepatitis C virus infection. 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, MA.
Pol, S., Thiers, V., Nousbaum, J. B., et al. (1995). The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology, 108, 581–583.
Pybus, O. G. & Gray, R. R. (2013) Virology: the virus whose family expanded. Nature, 498, 310–311.
Pybus, O. G., Rambaut, A. & Harvey, P. H. (2000). An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics, 155, 1429–1437.
Pybus, O. G., Charleston, M. A., Gupta, S., et al. (2001). The epidemic behaviour of the hepatitis C virus. Science, 292, 2323–2325.
Pybus, O. G., Drummond, A. J., Nakano, T., Robertson, B. H. & Rambaut, A. (2003). The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Molecular Biology and Evolution, 20, 381–387.
Pybus, O. G., Cochrane, A., Holmes, E. C. & Simmonds, P. (2005). The hepatitis C virus epidemic among injecting drug users. Infection Genetics Evolution, 5, 131–139.
Pybus, O. G., Markov, P. V., Wu, A. & Tatem, A. (2007). Investigating the endemic transmission of the hepatitis C virus. International Journal for Parasitology, 37, 839–849.
Pybus, O. G., Barnes, E, Taggart, R., et al. (2009). The genetic history of the hepatitis C virus in East Asia. Journal of Virology, 83, 1071–1082.
Quan, P. L., Firth, C., Conte, J. M., et al. (2013) Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proceedings of the National Academy of Sciences USA, 110, 8194–8199.
Raghwani, J., Thomas, X. V., Koekkoek, S. M., et al. (2012). Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b. Journal of Virology, 86, 2212–2220.
Ray, S. C., Arthur, R. R., Carella, A., Bukh, J. & Thomas, D. L. (2000). Genetic epidemiology of hepatitis C virus throughout Egypt. Journal of Infectious Diseases, 182, 698–707.
Robertson, B., Myers, G., Howard, C., et al. (1998). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Archives of Virology 143, 2493–503.
Roque-Afonso, A. M., Ducoulombier, D., Di Liberto, G., et al. (2005). Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. Journal of Virology, 79, 6349–6357.
Rose, R., Markov, P. V., Lam, T. T. & Pybus, O. G. (2013). Viral evolution explains the associations among hepatitis C virus genotype, clinical outcomes, and human genetic variation. Infection, Genetics & Evolution, 20, 418–421.
Salemi, M. & Vandamme, A. M. (2002). Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. Journal of Molecular Evolution, 54, 62–70.
Seeff, L. B., Miller, R. N., RabkinC. S., et al. (2000). 45-year follow-up of hepatitis C virus infection in healthy young adults. Annals of Internal Medicine, 132, 105–111.
Shepard, C. W, Finelli, L. & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases, 5, 558–567.
Sheridan, I., Pybus, O. G., Holmes, E. C. & Klenerman, P. (2004). High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. Journal of Virology, 78, 3447–3454.
Simmonds, P., Holmes, E. C., Cha, T. A., et al. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology, 74, 2391–2399.
Simmonds, P., Bukh, J., Combet, C., et al. (2005). Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology, 42, 962–973.
Simons, J. N., Leary, T. P., Dawson, G. J., et al. (1995a). Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine, 1, 564–569.
Simons, J. N., Pilot-Matias, T. J., Leary, T. P., et al (1995b). Identification of two flavivirus-like genomes in the GB hepatitis agent. Proceedings of the National Academy of Sciences USA, 92, 3401–3405.
Smith, D. B., Pathirana, S., Davidson, F., et al. (1997). The origin of hepatitis C virus genotypes. Journal of General Virology, 78, 321–328
Sobesky, R., Feray, C., Rimlinger, F., et al. (2007). Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology, 46, 1704–1712.
Stadler, T., Kühnert, D., Bonhoeffer, S. & Drummond, A. J. ( 2013). Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV). Proceedings of the National Academy of Sciences USA, 110, 228–233.
Stapleton, J. T., Foung, S., Muerhoff, A. S., Bukh, J. & Simmonds, P. (2011). The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. The Journal of General Virology, 92, 233–246.
Stiffler, J. D., Nguyen, M., Sohn, J. A., et al. (2009). Focal distribution of hepatitis C virus RNA in infected livers. PLoS One, 4, e6661.
Strickland, G. T. (2010). An epidemic of hepatitis C virus infection while treating endemic infectious diseases in Equatorial Africa more than a half century ago: did it also jump-start the AIDS pandemic?Clinical Infectious Diseases, 51, 785–787.
Stumpf, M. P. H. & Pybus, O. G. (2002). Genetic diversity and models of viral evolution for the hepatitis C virus. FEMS Microbiology Letters, 214, 143–152
Sullivan, D. G., Bruden, D., Deubner, H., et al. (2007). Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. Journal of Infectious Diseases, 196, 239–248.
Tanaka, Y., Hanada, K., Mizokami, M., et al. (2002). A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proceedings of the National Academy of Sciences USA, 99, 15584–15589.
Terrault, N. A. (2002). Sexual activity as a risk factor for hepatitis C. Hepatology, 36, S99–S105.
Thomas, D. L., Villano, S. A., Riester, K. A., et al. (1998). Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. The Journal of Infectious Diseases, 177, 1480–1488.
Thomas, F., Nicot, F., Sandres-Sauné, K., et al. (2007). Genetic diversity of HCV genotype 2 strains in south western France. Journal of Medical Virology, 79, 26–34.
Thomson, E. C., Fleming, V. M., Main, J., et al. (2011). Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut, 60, 837–845.
van Asten, L., Verhaest, I., Lamzira, S., et al. (2004). Spread of hepatitis C virus among European injection drug users infected with HIV: a phylogenetic analysis. Journal of Infectious Diseases, 189, 292–302.
van de Laar, T., Pybus, O. G., Bruisten, S., et al. (2009). Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology, 136, 1609–1617.
Verbeeck, J., Maes, P., Lemey, P., et al. (2006). Investigating the origin and spread of hepatitis C virus genotype 5a. Journal of Virology, 80, 4220–4226.
Wakita, T., Pietschmann, T., Kato, T., et al. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine, 11, 791–796.
Wang, H., Yuan, Z., Barnes, E., et al. (2013). Eight novel hepatitis C virus genomes reveal the changing taxonomic structure of genotype 6. Journal of General Virology, 94, 76–80.
Wansbrough-Jones, M., Frimpong, E., Cant, B., et al. (1998). Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 496–499.
Wilson, G. K. & Stamataki, Z. (2012). In vitro systems for the study of hepatitis C virus infection. International Journal of Hepatology, 2012, doi:10.1155/2012/292591.
World Health Organization (1999). Hepatitis C: global prevalence (update). Weekly Epidemiological Record, 49.